Left ventricular response to β-adrenergic stimulation in aging rats

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 55, Issue 1, 2000, Pages

  Masson, Serge ^a   Arosio, Beatrice ^b   Fiordaliso, Fabio ^a   Gagliano, Nicoletta ^b   Calvillo, Laura ^a   Santambrogio, Daniela ^b   D'Aquila, Silvia ^a   Vergani, Carlo ^b   Latini, Roberto ^a   Annoni, Giorgio ^b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CATECHOLAMINE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; ISOPRENALINE; MESSENGER RNA; OSTEONECTIN; PROCOLLAGEN; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3;

ADAPTATION; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CHRONOTROPISM; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HEART WEIGHT; KIDNEY MASS; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT;

ANIMALIA; RATTUS NORVEGICUS;

EID: 18144432812     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/55.1.B35     Document Type: Article

References (47)

1. Sharpe N, Doughty R. Epidemiology of heart failure and ventricular dysfunction. Lancet. 1998;352:3-7.
2. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971; 285:1441-1446.
3. Maggioni AP, Maseri A, Fresco C, et al. Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. N Engl J Med. 1993;329:1442-1448.
4. Lechat P, Packer M, Chalon S, Cucherat M, Arab T, Boissel JP. Clinical effects of β-adrenergic blockade in chronic heart failure. A meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation. 1998; 98:1184-1191.
5. Anversa P, Hiller B, Ricci R, Guideri G, Olivetti G. Myocyte cell loss and myocyte hypertrophy in the aging rat heart. J Am Coll Cardiol. 1986;8: 1441-1448.
6. Olivetti G, Melissari M, Capasso JM, Anversa P. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ Res. 1991;68:1560-1568.
7. Olivetti G, Melissari M, Balbi T, et al. Myocyte cellular hypertrophy is responsible for ventricular remodelling in the hypertrophied heart of middle aged individuals in the absence of cardiac failure. Cardiovasc Res. 1994; 28:1199-1208.
8. Kajstura J, Cheng W, Sarangarajan R, et al. Necrotic and apoptotic myocyte cell death in the aging heart of Fischer 344 rats. Am J Physiol. 1996;271:H1215-H1228.
9. Masoro, EJ, ed. Handbook of Physiology. Section II: Aging. New York: Oxford University Press; 1995:433-474.
10. Brand T, Sharma HS, Schaper W. Expression of nuclear proto-oncogenes in isoproterenol-induced cardiac hypertrophy. J Mol Cell Cardiol. 1993;25:1325-1337.
11. Rona G. Catecholamine cardiotoxicity. J Mol Cell Cardiol. 1985;17: 291-306.
12. Bhambi B, Eghbali M. Effect of norepinephrine on myocardial collagen gene expression and response of cardiac fibroblasts after norepinephrine treatment. Am J Pathol. 1991;139:1131-1142.
13. Omura T, Kim S, Takeuchi K, Iwao H, Takeda T. Transforming growth factor β1 and extracellular matrix gene expression in isoprenaline induced cardiac hypertrophy: effects of inhibition of the renin-angiotensin system. Cardiovasc Res. 1994;28:1835-1842.
14. Boluyt MO, Long X, Eschenhagen T, et al. Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart. Am J Physiol. 1995;269:H638-H647.
15. Communal C, Singh K, Pimentel DR, Colucci WS. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the β-adrenergic pathway. Circulation. 1998;98:1329-1334.
16. Shizukuda Y, Buttrick PM, Geenen DL, Borczuk AC, Kitsis RN, Sonnenblick EH. β-adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. Am J Physiol. 1998;275: H961-H968.
17. Pick R, Jalil JE, Janicki JS, Weber KT. The fibrillar nature and structure of isoproterenol-induced myocardial fibrosis in the rat. Am J Pathol. 1989; 134:365-371.
18. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
19. Cittadini A, Grossman JD, Napoli R, et al. Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction. J Am Coll Cardiol. 1997;29:1109-1116.
20. Engelmann GL, Vitullo JC, Gerrity RG. Morphometric analysis of cardiac hypertrophy during development, maturation, and senescence in spontaneously hypertensive rats. Circ Res. 1987;60:487-494.
21. Klein CE, Nies A, Gerber J. The effect of age on the β-adrenergic lipolytic response in healthy humans. Clin Pharmacol Ther. 1994;56:210-216.
22. Roth DA, White CD, Podolin DA, Mazzeo RS. Alterations in myocardial signal transduction due to aging and chronic dynamic exercise. J Appl Physiol. 1998;84:177-184.
23. Arnold JMO, McDevitt DG. Contribution of the vagus to the haemodynamic responses following intravenous boluses of isoprenaline. Br J Clin Pharmacol. 1983;15:423-429.
24. Arnold JMO, McDevitt DG. Vagal activity is increased during intravenous isoprenaline infusion in man. Br J Clin Pharmacol. 1984;18:311-316.
25. White M, Leenen FHH. Aging and cardiovascular responsiveness to β-agonist in humans: role of changes in β-receptor responses versus baroreflex activity. Clin Pharmacol Ther. 1994;56:543-553.
26. Eschenhagen T, Mende U, Diederich M, et al. Long term β-adrenoceptor-mediated up-regulation of Giα and Goα mRNA levels and pertussis toxin-sensitive guanine nucleotide-binding proteins in rat heart. Mol Pharmacol. 1992;42:773-783.
27. Isoyama S, Wei JY, Izumo S, Fort P, Schoen FJ, Grossman W. Effect of age on the development of cardiac hypertrophy produced by aortic constriction in the rat. Circ Res. 1987;61:337-345.
28. Isoyama S, Grossman W, Wei JY. Effect of age on myocardial adaptation to volume overload in the rat. J Clin Invest. 1988;81:1850-1857.
29. Cheng W, Reiss K, Li P, et al. Aging does not affect the activation of the myocyte insulin-like growth factor-1 autocrine system after infarction and ventricular failure in Fischer 344 rats. Circ Res. 1996;78:536-546.
30. Raya TE, Gaballa M, Anderson P, Goldman S. Left ventricular function and remodeling after myocardial infarction in aging rats. Am J Physiol. 1997;273:H2652-H2658.
31. Masson S, Arosio B, Luvarà G, et al. Remodelling of cardiac extracellular matrix during β-adrenergic stimulation: up-regulation of SPARC in the myocardium of adult rats. J Mol Cell Cardiol. 1998;30:1505-1514.
32. Jalil JE, Janicki JS, Pick R, Abrahams C, Weber KT. Fibrosis-induced reduction of endomyocardium in the rat after isoproterenol treatment. Circ Res. 1989;65:258-264.
33. McKenzie JC, Kelley KB, Merisko-Liversidge EM, Kennedy J, Klein RM. Developmental pattern of ventricular atrial natriuretic peptide (ANP) expression in chronically hypoxic rats as an indicator of the hypertrophic process. J Mol Cell Cardiol. 1994;26:753-767.
34. Vikstrom KL, Bohlmeyer T, Factor SM, Leinwand LA. Hypertrophy, pathology, and molecular markers of cardiac pathogenesis. Circ Res. 1998;82:773-778.
35. Schlüter K-D, Zhou XJ, Piper HM. Induction of hypertrophic responsiveness to isoproterenol by TGF-β in adult rat cardiomyocytes. Am J Physiol. 1995;269:C1311-C1316.
36. Brand T, Schneider MD. The TGFβ superfamily in myocardium ligands, receptors, transduction, and function. J Mol Cell Cardiol. 1995;27:5-18.
37. Besse S, Robert V, Assayag P, Delcayre C, Swynghedauw B. Nonsynchronaus changes in myocardial collagen mRNA and protein during aging: effect of DOCA-salt hypertension. Am J Physiol. 1994;267: H2237-H2244.
38. Annoni G, Luvarà G, Arosio B, et al. Age-dependent expression of fibrosis-related genes and collagen deposition in the rat myocardium. Mech Ageing Dev. 1998;101:57-72.
39. Weber KT. Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol. 1989;13:1637-1652.
40. Mays; PK, McAnulty RJ, Campa JS, Laurent GJ. Age-related changes in collagen synthesis and degradation in rat tissues. Importance of degradation of newly synthesized collagen in regulating collagen production. Biochem J. 1991;276:307-313.
41. Robert V, Besse S, Sabri A, et al. Differential regulation of matrix metalloproteinases associated with aging and hypertension in the rat heart. Lab Invest. 1997;76:729-738.
42. Thomas DP, McCormick RJ, Zimmerman SD, Vadlamudi RK, Gosselin LE, Vadlanudi RK. Aging- and training-induced alterations in collagen characteristics of rat left ventricle and papillary muscle. Am J Physiol. 1992;263:H778-H783.
43. Lane TF, Sage EH. The biology of SPARC, a protein that modulates cell-matrix interactions. FASEB J. 1994;8:163-173.
44. Sage EH, Bornstein P. Extracellular proteins that modulate cell-matrix interactions: SPARC, tenascin, and thrombospondin. J Biol Chem. 1991; 266:14831-14834.
45. Assayag P, Charlemagne D, de Leiris J, et al. Senescent heart compared with pressure overload-induced hypertrophy. Hypertension. 1997;29: 15-21.
46. Assayag P, Charlemagne D, Marty I, et al. Effects of sustained low-flow ischemia on myocardial function and calcium-regulating proteins in adult and senescent rat hearts. Cardiovasc Res. 1998;38:169-180.
47. Wei JY. Age and the cardiovascular system. N Engl J Med. 1992;327: 1735-1739.